Business · 01/11/2002Updated: 10/17/2026 · 1 min read
FDA Releases Guidance on Evaluating Immunotoxicity of Investigational New Drugs
Summary
The Food and Drug Administration (FDA) has made available a new guidance document for industry, outlining recommendations for assessing immune function effects in toxicology studies of investigational new drugs (INDs)
Original source language: Federal Register — Food and Drug AdministrationOpen original release →